Metabolism of the one-ring open metabolites of the cardioprotective drug dexrazoxane to its active metal-chelating form in the rat
- PMID:15980099
- DOI: 10.1124/dmd.105.005546
Metabolism of the one-ring open metabolites of the cardioprotective drug dexrazoxane to its active metal-chelating form in the rat
Abstract
Dexrazoxane (ICRF-187) is clinically used as a doxorubicin cardioprotective agent and may act by preventing iron-based oxygen free radical damage through the iron-chelating ability of its fully hydrolyzed metabolite ADR-925 (N,N'-[(1S)-1-methyl-1,2-ethanediyl]-bis[(N-(2-amino-2-oxoethyl)]glycine). Dexrazoxane undergoes initial metabolism to its two one-ring open intermediates and is then further metabolized to its active metal ion-binding form ADR-925. The metabolism of these intermediates to the ring-opened metal-chelating product ADR-925 has been determined in a rat model to identify the mechanism by which dexrazoxane is activated. The plasma concentrations of both intermediates rapidly decreased after their i.v. administration to rats. A maximum concentration of ADR-925 was detected 2 min after i.v. bolus administration, indicating that these intermediates were both rapidly metabolized in vivo to ADR-925. The kinetics of the initial appearance of ADR-925 was consistent with formation rate-limited metabolism of the intermediates. After administration of dexrazoxane or its two intermediates, ADR-925 was detected in significant levels in both heart and liver tissue but was undetectable in brain tissue. The rapid rate of metabolism of the intermediates was consistent with their hydrolysis by tissue dihydroorotase. The rapid appearance of ADR-925 in plasma may make ADR-925 available to be taken up by heart tissue and bind free iron. These studies showed that the two one-ring open metabolites of dexrazoxane were rapidly metabolized in the rat to ADR-925, and thus, these results provide a mechanism by which dexrazoxane is activated to its active metal-binding form.
Similar articles
- The doxorubicin-cardioprotective drug dexrazoxane undergoes metabolism in the rat to its metal ion-chelating form ADR-925.Schroeder PE, Hasinoff BB.Schroeder PE, et al.Cancer Chemother Pharmacol. 2002 Dec;50(6):509-13. doi: 10.1007/s00280-002-0538-z. Epub 2002 Oct 31.Cancer Chemother Pharmacol. 2002.PMID:12451479
- Metabolism of the cardioprotective drug dexrazoxane and one of its metabolites by isolated rat myocytes, hepatocytes, and blood.Schroeder PE, Wang GQ, Burczynski FJ, Hasinoff BB.Schroeder PE, et al.Drug Metab Dispos. 2005 Jun;33(6):719-25. doi: 10.1124/dmd.104.003186. Epub 2005 Mar 11.Drug Metab Dispos. 2005.PMID:15764716
- Relative plasma levels of the cardioprotective drug dexrazoxane and its two active ring-opened metabolites in the rat.Hasinoff BB, Aoyama RG.Hasinoff BB, et al.Drug Metab Dispos. 1999 Feb;27(2):265-8.Drug Metab Dispos. 1999.PMID:9929514
- Utility of dexrazoxane for the reduction of anthracycline-induced cardiotoxicity.Jones RL.Jones RL.Expert Rev Cardiovasc Ther. 2008 Nov;6(10):1311-7. doi: 10.1586/14779072.6.10.1311.Expert Rev Cardiovasc Ther. 2008.PMID:19018683Review.
- Clinical pharmacology of dexrazoxane.Hochster HS.Hochster HS.Semin Oncol. 1998 Aug;25(4 Suppl 10):37-42.Semin Oncol. 1998.PMID:9768822Review.
Cited by
- Mitochondrial iron-sulfur clusters: Structure, function, and an emerging role in vascular biology.Read AD, Bentley RE, Archer SL, Dunham-Snary KJ.Read AD, et al.Redox Biol. 2021 Nov;47:102164. doi: 10.1016/j.redox.2021.102164. Epub 2021 Oct 12.Redox Biol. 2021.PMID:34656823Free PMC article.Review.
- Dexrazoxane Shows No Protective Effect in the Acute Phase of Reperfusion during Myocardial Infarction in Pigs.Kamat P, Vandenberghe S, Christen S, Bongoni AK, Meier B, Rieben R, Khattab AA.Kamat P, et al.PLoS One. 2016 Dec 21;11(12):e0168541. doi: 10.1371/journal.pone.0168541. eCollection 2016.PLoS One. 2016.PMID:28002439Free PMC article.
- Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection.Stěrba M, Popelová O, Vávrová A, Jirkovský E, Kovaříková P, Geršl V, Simůnek T.Stěrba M, et al.Antioxid Redox Signal. 2013 Mar 10;18(8):899-929. doi: 10.1089/ars.2012.4795. Epub 2012 Oct 12.Antioxid Redox Signal. 2013.PMID:22794198Free PMC article.Review.
- Natural dolomitic limestone-catalyzed synthesis of benzimidazoles, dihydropyrimidinones, and highly substituted pyridines under ultrasound irradiation.Godugu K, Yadala VDS, Pinjari MKM, Gundala TR, Sanapareddy LR, Nallagondu CGR.Godugu K, et al.Beilstein J Org Chem. 2020 Aug 3;16:1881-1900. doi: 10.3762/bjoc.16.156. eCollection 2020.Beilstein J Org Chem. 2020.PMID:32802206Free PMC article.
- Doxorubicin-Induced Cardiomyopathy in Children.Mancilla TR, Iskra B, Aune GJ.Mancilla TR, et al.Compr Physiol. 2019 Jun 12;9(3):905-931. doi: 10.1002/cphy.c180017.Compr Physiol. 2019.PMID:31187890Free PMC article.Review.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous